Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ImmunoSep: Personalized Immunotherapy in Sepsis
NCT04990232Phase 2Completed
- Sponsor
- Hellenic Institute for the Study of Sepsis
- Start
- Jul 2021
- Primary completion
- Feb 2024
- Modality
- Cytokines & Interferons
- Countries
- 6
01
Overview
A Phase 2 trial of anakinra, interferon gamma-1b in sepsis, sponsored by Hellenic Institute for the Study of Sepsis. Started Jul 2021; status: completed.
02
Drugs
anakinrainterferon gamma-1b
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT04990232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04990232.